Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Chi Chiu Mok. (2019) The Jakinibs in systemic lupus erythematosus: progress and prospects. Expert Opinion on Investigational Drugs 28:1, pages 85-92.
Read now
Read now
Aleksander Lenert, Timothy B Niewold & Petar Lenert. (2017) Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date. Drug Design, Development and Therapy 11, pages 747-757.
Read now
Read now
Chi Chiu Mok. (2017) Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art. Expert Review of Clinical Immunology 13:7, pages 677-692.
Read now
Read now
Chi Chiu Mok. (2017) Therapeutic monitoring of the immuno-modulating drugs in systemic lupus erythematosus. Expert Review of Clinical Immunology 13:1, pages 35-41.
Read now
Read now
Hiroto Tsuboi, Isao Matsumoto, Shinya Hagiwara, Tomoya Hirota, Hiroyuki Takahashi, Hiroshi Ebe, Masahiro Yokosawa, Mizuki Yagishita, Hidenori Takahashi, Izumi Kurata, Ayako Ohyama, Fumika Honda, Hiromitsu Asashima, Haruka Miki, Naoto Umeda, Yuya Kondo, Shintaro Hirata, Kazuyoshi Saito, Yoshiya Tanaka, Yoshiro Horai, Hideki Nakamura, Atsushi Kawakami & Takayuki Sumida. (2016) Effectiveness of abatacept for patients with Sjögren’s syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjögren’s syndrome Endocrinopathy) trial. Modern Rheumatology 26:6, pages 891-899.
Read now
Read now
Chi Chiu Mok. (2016) Treat-to-target in systemic lupus erythematosus: are we there yet?. Expert Review of Clinical Pharmacology 9:5, pages 675-680.
Read now
Read now
Articles from other publishers (14)
Samar A Soliman, Anam Haque, Sherene Mason, Larry A Greenbaum, M John Hicks, Chandra Mohan & Scott E Wenderfer. (2021) Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research Consortium. Lupus 30:9, pages 1394-1404.
Crossref
Crossref
Amayrani Abrego-Peredo, Héctor Romero-Ramírez, Enrique Espinosa, Gabriela López-Herrera, Fabio García-García, Mónica Flores-Muñoz, Claudia Sandoval-Montes & Juan Carlos Rodríguez-Alba. (2020) Naringenin mitigates autoimmune features in lupus-prone mice by modulation of T-cell subsets and cytokines profile. PLOS ONE 15:5, pages e0233138.
Crossref
Crossref
Dominik Samotij & Adam Reich. (2019) Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review. BioMed Research International 2019, pages 1-17.
Crossref
Crossref
Chi Chiu Mok. (2018) Is Treat-to-target in Lupus Nephritis Realistic in Clinical Practice?. Current Rheumatology Reviews 15:1, pages 2-6.
Crossref
Crossref
Chi Chiu Mok, Eric T. Bro, Ling Yin Ho, Ravinder J. Singh & Paul J. Jannetto. (2018) Serum 25-hydroxyvitamin D3 levels and flares of systemic lupus erythematosus: a longitudinal cohort analysis. Clinical Rheumatology 37:10, pages 2685-2692.
Crossref
Crossref
Chi Chiu Mok. (2017) Calcineurin inhibitors in systemic lupus erythematosus. Best Practice & Research Clinical Rheumatology 31:3, pages 429-438.
Crossref
Crossref
Chi Chiu Mok, Hannah J. Penn, Kar Li Chan, Sau Mei Tse, Loralie J. Langman & Paul J. Jannetto. (2016) Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis. Arthritis Care & Research 68:9, pages 1295-1302.
Crossref
Crossref
Chi Chiu Mok, Hui Hua Ding, Marwa Kharboutli & Chandra Mohan. (2016) Axl, Ferritin, Insulin‐Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus. Arthritis Care & Research 68:9, pages 1303-1309.
Crossref
Crossref
Chi Chiu Mok. (2016) Con: Cyclophosphamide for the treatment of lupus nephritis. Nephrology Dialysis Transplantation 31:7, pages 1053-1057.
Crossref
Crossref
C. C. Mok. (2016) Towards new avenues in the management of lupus glomerulonephritis. Nature Reviews Rheumatology 12:4, pages 221-234.
Crossref
Crossref
Lele Guo, Wen Liu, Tingting Lu, Wenjie Guo, Jian Gao, Qiong Luo, Xuefeng Wu, Yang Sun, Xudong Wu, Yan Shen & Qiang Xu. (2015) Decrease of Functional Activated T and B Cells and Treatment of Glomerulonephitis in Lupus-Prone Mice Using a Natural Flavonoid Astilbin. PLOS ONE 10:4, pages e0124002.
Crossref
Crossref
Chi Chiu Mok. (2015) Special issue on systemic lupus erythematosus in Asia. International Journal of Rheumatic Diseases 18:2, pages 112-112.
Crossref
Crossref
Chi Chiu Mok. (2015) Current role of rituximab in systemic lupus erythematosus. International Journal of Rheumatic Diseases 18:2, pages 154-163.
Crossref
Crossref
Chi Chiu Mok, Mark Kosinski, Ling Yin Ho, Kar Li Chan & Meenakshi Jolly. (2015) Validation of the LupusPRO in Chinese Patients From Hong Kong With Systemic Lupus Erythematosus. Arthritis Care & Research 67:2, pages 297-304.
Crossref
Crossref